Showing results (31-40 of 35) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Molecular Pharmaceutics|November 2, 2023
Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral AgentRaju Subramanian, Jennifer Tang, Jim Zheng, et al.The Journal of Pharmacology and Experimental Therapeutics|August 8, 2024
Lenacapavir Exhibits Atropisomerism-Mechanistic Pharmacokinetics and Disposition Studies of Lenacapavir Reveal Intestinal Excretion as a Major Clearance PathwayJim Zheng, Bing Lu, Gavin Carr, et al.Antimicrobial Agents and Chemotherapy|June 14, 2021
Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung CellsRuidong Li, Albert Liclican, Yili Xu, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 27, 2004
The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse modelAngela Doran, R Scott Obach, Bill J Smith, et al.Journal of Medicinal Chemistry|October 1, 2025
Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure ProphylaxisEda Canales, Winston Tse, Scott D Schroeder, et al.Pageof 4